×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Collegium Pharmaceutical Inc. (COLL) NASDAQ

$35.83 0.35 (0.99%)

Market Cap: $1.16B

As of 04/25/24 03:59 PM EDT. Market closed.

(COLL)

Collegium Pharmaceutical Inc. (COLL)
NASDAQ

$35.83
0.35 (0.99%)

Market Cap: $1.16B

As of 04/25/24 03:59 PM EDT. Market closed.

Add to Portfolio

collegium pharmaceutical, inc. is a specialty pharmaceutical company developing and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. with a substantial number of patients suffering from chronic pain, collegium is committed to developing and commercializing a portfolio of products that address the ... read more

COMPANY PROFILE
Sector
Industry
CEO
Joseph Ciaffoni
Full Time Employees
252
CEO Compensation (Base)
$317,308
CEO Compensation (Total)
$4.64M
URL
Address
100 Technology Center Dr, Massachusetts, Stoughton, 02072-4710.
Sector
Industry
CEO
Joseph Ciaffoni
Full Time Employees
252
CEO Compensation (Base)
$317,308
CEO Compensation (Total)
$4.64M
Address
100 Technology Center Dr, Massachusetts, Stoughton, 02072-4710.
PRICE CHART FOR COLLEGIUM PHARMACEUTICAL INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$35.31
Previous Close
$35.48
Days Range
$35.35 - $35.95
52 week range
$20.83 - $40.95
Volume
200,391
Avg. Volume (30 days)
354,082
Market Cap
$1.16B
Dividend Yield
-
P/E
24.10
Shares Outstanding
32,705,747
Open
$35.31
Previous Close
$35.48
Days Range
$35.35 - $35.95
52 week range
$20.83 - $40.95
Volume
200,391
Avg. Volume (30 days)
354,082
Market Cap
$1.16B
Dividend Yield
-
P/E
24.10
Shares Outstanding
32,705,747
FINANCIAL STATEMENTS FOR COLLEGIUM PHARMACEUTICAL INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR COLLEGIUM PHARMACEUTICAL INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Smith Thomas BEVP and Chief Medical OfficerFeb 29, 2024 Sale$36.7699536,58063,409Mar 04, 2024, 04:26 PM
Dreyer ScottEVP & Chief Commercial OfficerFeb 26, 2024 Sale$36.4310,000364,270139,582Feb 28, 2024, 04:14 PM
Tupper ColleenEVP & Chief Financial OfficerFeb 12, 2024 Option Exercise$33.7026,321887,018160,008Feb 14, 2024, 04:15 PM
Dreyer ScottEVP & Chief Commercial OfficerFeb 12, 2024 Option Exercise$33.7029,6901,000,553159,063Feb 14, 2024, 04:14 PM
Smith Thomas BEVP and Chief Medical OfficerFeb 12, 2024 Option Exercise$33.703,199107,80665,704Feb 14, 2024, 04:14 PM
Kuhlmann Shirley R.EVP and General CounselFeb 12, 2024 Option Exercise$33.7031,7561,070,177175,019Feb 14, 2024, 04:14 PM
Ciaffoni JosephPresident and CEOFeb 12, 2024 Option Exercise$33.70128,8674,342,818526,289Feb 14, 2024, 04:13 PM
Dreyer ScottEVP & Chief Commercial OfficerJan 16, 2024 Sale$32.2823,560760,519111,322Jan 18, 2024, 04:19 PM
Ciaffoni JosephPresident and CEODec 21, 2023 Option Exercise$21.344,35792,978279,357Dec 22, 2023, 04:36 PM
Ciaffoni JosephPresident and CEODec 21, 2023 Sale$30.384,357132,377275,000Dec 22, 2023, 04:36 PM
Ciaffoni JosephPresident and CEODec 20, 2023 Option Exercise$21.3426,454564,528301,454Dec 20, 2023, 05:51 PM
Ciaffoni JosephPresident and CEODec 19, 2023 Option Exercise$21.3414,516309,771289,516Dec 20, 2023, 05:51 PM
Ciaffoni JosephPresident and CEODec 18, 2023 Option Exercise$21.3427,798593,209302,798Dec 20, 2023, 05:51 PM
Ciaffoni JosephPresident and CEODec 20, 2023 Sale$30.4026,454804,210275,000Dec 20, 2023, 05:51 PM
Ciaffoni JosephPresident and CEODec 19, 2023 Sale$30.0314,516435,942275,000Dec 20, 2023, 05:51 PM
Ciaffoni JosephPresident and CEODec 18, 2023 Sale$30.0427,798834,935275,000Dec 20, 2023, 05:51 PM
Kuhlmann Shirley R.EVP and General CounselNov 27, 2023 Option Exercise$15.9025,600407,040145,118Nov 29, 2023, 04:32 PM
Kuhlmann Shirley R.EVP and General CounselNov 27, 2023 Sale$25.7825,600660,014119,518Nov 29, 2023, 04:32 PM
Kuhlmann Shirley R.EVP and General CounselJun 26, 2023 Sale$21.7217,984390,633120,881Jun 28, 2023, 04:08 PM
Ciaffoni JosephPresident and CEOJun 02, 2023 Sale$21.6031,272675,424276,000Jun 02, 2023, 07:08 PM
Ciaffoni JosephPresident and CEOJun 01, 2023 Sale$22.0931,272690,758306,272Jun 02, 2023, 07:08 PM
Ciaffoni JosephPresident and CEOMay 31, 2023 Sale$21.8731,272683,797337,544Jun 01, 2023, 04:15 PM
Ciaffoni JosephPresident and CEOMay 30, 2023 Sale$21.9031,271684,907368,816Jun 01, 2023, 04:15 PM
Tupper ColleenEVP & Chief Financial OfficerMar 15, 2023 Sale$23.7731,640752,165105,420Mar 17, 2023, 04:11 PM
Kuhlmann Shirley R.EVP and General CounselFeb 10, 2023 Option Exercise$26.7524,046643,231167,068Feb 14, 2023, 05:18 PM
Kuhlmann Shirley R.EVP and General CounselFeb 13, 2023 Sale$26.8821,811586,280137,502Feb 14, 2023, 05:18 PM
Tupper ColleenEVP & Chief Financial OfficerFeb 10, 2023 Option Exercise$26.7510,854290,345140,947Feb 14, 2023, 05:17 PM
Ciaffoni JosephPresident and CEOFeb 10, 2023 Option Exercise$26.75103,8572,778,175459,823Feb 14, 2023, 05:16 PM
Ciaffoni JosephPresident and CEOFeb 13, 2023 Option Exercise$15.9011,250178,875411,337Feb 14, 2023, 05:16 PM
Ciaffoni JosephPresident and CEOFeb 13, 2023 Sale$26.8811,250302,400400,087Feb 14, 2023, 05:16 PM
Dreyer ScottEVP & Chief Commercial OfficerFeb 10, 2023 Option Exercise$26.7521,326570,471155,003Feb 14, 2023, 05:15 PM
Dreyer ScottEVP & Chief Commercial OfficerJan 09, 2023 Sale$27.3917,834488,554110,208Jan 11, 2023, 04:06 PM
Heffernan Michael ThomasDirectorDec 27, 2022 Option Exercise$16.1519,815320,01244,018Dec 27, 2022, 07:17 PM
Heffernan Michael ThomasDirectorDec 23, 2022 Option Exercise$16.154,98980,57233,012Dec 27, 2022, 07:17 PM
Heffernan Michael ThomasDirectorDec 22, 2022 Option Exercise$16.152373,82828,260Dec 27, 2022, 07:17 PM
Heffernan Michael ThomasDirectorDec 23, 2022 Sale$23.004,989114,74728,023Dec 27, 2022, 07:17 PM
Heffernan Michael ThomasDirectorDec 22, 2022 Sale$23.002375,45128,023Dec 27, 2022, 07:17 PM
Heffernan Michael ThomasDirectorDec 27, 2022 Sale$23.7319,815470,25328,023Dec 27, 2022, 07:17 PM
Ciaffoni JosephPresident and CEODec 27, 2022 Sale$23.752,20452,341249,150Dec 27, 2022, 07:16 PM
Ciaffoni JosephPresident and CEODec 23, 2022 Sale$23.001473,381250,954Dec 27, 2022, 07:16 PM
Ciaffoni JosephPresident and CEODec 22, 2022 Sale$23.001102,530251,101Dec 27, 2022, 07:16 PM
Heffernan Michael ThomasDirectorDec 19, 2022 Option Exercise$16.153,60658,23731,629Dec 21, 2022, 07:28 PM
Heffernan Michael ThomasDirectorDec 21, 2022 Option Exercise$16.1546,600752,59074,623Dec 21, 2022, 07:28 PM
Heffernan Michael ThomasDirectorDec 20, 2022 Option Exercise$16.1533,758545,19261,781Dec 21, 2022, 07:28 PM
Heffernan Michael ThomasDirectorDec 21, 2022 Sale$23.1146,6001,076,92628,023Dec 21, 2022, 07:28 PM
Heffernan Michael ThomasDirectorDec 20, 2022 Sale$23.0833,758779,13528,023Dec 21, 2022, 07:28 PM
Heffernan Michael ThomasDirectorDec 19, 2022 Sale$23.043,60683,08228,023Dec 21, 2022, 07:28 PM
Ciaffoni JosephPresident and CEODec 19, 2022 Sale$23.011,13426,093267,919Dec 21, 2022, 07:28 PM
Ciaffoni JosephPresident and CEODec 21, 2022 Sale$23.117,333169,466251,211Dec 21, 2022, 07:28 PM
Ciaffoni JosephPresident and CEODec 20, 2022 Sale$23.079,375216,281258,544Dec 21, 2022, 07:28 PM
Heffernan Michael ThomasDirectorDec 13, 2022 Option Exercise$15.10161,6872,441,404189,710Dec 14, 2022, 06:06 PM
Heffernan Michael ThomasDirectorDec 12, 2022 Option Exercise$15.0927,920421,33455,943Dec 14, 2022, 06:06 PM
Heffernan Michael ThomasDirectorDec 13, 2022 Sale$22.16161,6873,582,98428,023Dec 14, 2022, 06:06 PM
Heffernan Michael ThomasDirectorDec 12, 2022 Sale$22.0127,920614,51928,023Dec 14, 2022, 06:06 PM
Ciaffoni JosephPresident and CEODec 01, 2022 Option Exercise$15.9076,6531,218,783400,106Dec 05, 2022, 06:16 PM
Ciaffoni JosephPresident and CEODec 02, 2022 Sale$23.0754,4001,255,008269,053Dec 05, 2022, 06:16 PM
Ciaffoni JosephPresident and CEODec 01, 2022 Sale$22.4776,6531,722,393323,453Dec 05, 2022, 06:16 PM
Ciaffoni JosephPresident and CEONov 28, 2022 Option Exercise$15.9043684323,496Nov 30, 2022, 05:59 PM
Ciaffoni JosephPresident and CEONov 28, 2022 Sale$22.0043946323,453Nov 30, 2022, 05:59 PM
Ciaffoni JosephPresident and CEONov 22, 2022 Option Exercise$15.90651,033323,518Nov 25, 2022, 06:11 PM
Ciaffoni JosephPresident and CEONov 22, 2022 Sale$22.00651,430323,453Nov 25, 2022, 06:11 PM
Ciaffoni JosephPresident and CEONov 18, 2022 Option Exercise$15.901,98931,625325,442Nov 22, 2022, 04:44 PM
Ciaffoni JosephPresident and CEONov 18, 2022 Sale$22.021,98943,798323,453Nov 22, 2022, 04:44 PM
Tupper ColleenEVP & Chief Financial OfficerOct 04, 2022 Sale$17.354,35075,47390,304Oct 06, 2022, 04:23 PM
Kuhlmann Shirley R.EVP and General CounselSep 15, 2022 Sale$18.0738,589697,303109,495Sep 16, 2022, 04:22 PM
Kuhlmann Shirley R.EVP and General CounselAug 11, 2022 Sale$20.013006,003148,084Aug 15, 2022, 04:34 PM
Dreyer ScottEVP & Chief Commercial OfficerJul 11, 2022 Option Exercise$17.4859410,383120,632Jul 13, 2022, 04:50 PM
Ciaffoni JosephPresident and CEOJul 01, 2022 Option Exercise$18.161,39425,315323,453Jul 06, 2022, 04:35 PM
Kuhlmann Shirley R.EVP and General CounselMar 16, 2022 Option Exercise$18.9973413,939148,384Mar 18, 2022, 04:03 PM
Ciaffoni JosephPresident and CEOMar 01, 2022 Sale$18.4776,0941,405,224335,858Mar 03, 2022, 04:14 PM
Tupper ColleenEVP & Chief Financial OfficerFeb 10, 2022 Option Exercise$17.634,05871,54395,891Mar 03, 2022, 04:13 PM
Dreyer ScottEVP & Chief Commercial OfficerFeb 18, 2022 Sale$21.6110,559228,180121,226Feb 28, 2022, 04:24 PM
Malamut RichardEVP and Chief Medical OfficerFeb 10, 2022 Option Exercise$17.636,300111,069132,102Feb 14, 2022, 06:49 PM
Tupper ColleenEVP & Chief Financial OfficerFeb 10, 2022 Option Exercise$17.634,05871,54388,891Feb 14, 2022, 06:38 PM
Ciaffoni JosephPresident and CEOFeb 10, 2022 Option Exercise$17.6352,997934,337429,784Feb 14, 2022, 06:37 PM
Kuhlmann Shirley R.EVP and General CounselFeb 10, 2022 Option Exercise$17.6311,179197,086153,330Feb 14, 2022, 06:37 PM
Dreyer ScottEVP & Chief Commercial OfficerFeb 10, 2022 Option Exercise$17.6310,659187,918135,801Feb 14, 2022, 06:36 PM
Dreyer ScottEVP & Chief Commercial OfficerJan 10, 2022 Option Exercise$19.0570113,35476,269Jan 12, 2022, 04:22 PM
Ciaffoni JosephPresident and CEOJan 03, 2022 Option Exercise$18.681,09020,361263,904Jan 05, 2022, 04:06 PM
Dreyer ScottEVP & Chief Commercial OfficerDec 15, 2021 Sale$18.335,693104,35376,970Dec 17, 2021, 04:33 PM
Kuhlmann Shirley R.EVP and General CounselSep 16, 2021 Option Exercise$19.6773414,43889,256Sep 20, 2021, 04:03 PM
Fleming Alison BEVP & Chief Technical OfficerAug 10, 2021 Option Exercise$19.031,38626,376143,694Aug 12, 2021, 04:03 PM
Ciaffoni JosephPresident and CEOAug 10, 2021 Option Exercise$19.031,38626,376264,994Aug 12, 2021, 04:01 PM
Dreyer ScottEVP & Chief Commercial OfficerJul 12, 2021 Option Exercise$23.1759513,78682,663Jul 14, 2021, 04:17 PM
Ciaffoni JosephPresident and CEOJul 01, 2021 Option Exercise$23.991,39433,442266,380Jul 06, 2021, 04:03 PM
Kuhlmann Shirley R.EVP and General CounselMay 10, 2021 Sale$22.777,000159,39089,990May 12, 2021, 04:06 PM
Malamut RichardEVP and Chief Medical OfficerApr 01, 2021 Option Exercise$23.383,11972,92293,558Apr 05, 2021, 07:07 PM
Fleming Alison BEVP & Chief Technical OfficerApr 01, 2021 Option Exercise$23.389,657225,781152,980Apr 05, 2021, 06:54 PM
Kuhlmann Shirley R.EVP and General CounselMar 16, 2021 Option Exercise$24.6973418,12296,990Mar 18, 2021, 04:07 PM
Heffernan Michael ThomasDirectorMar 15, 2021 Sale$25.3050,0751,266,7747,078Mar 17, 2021, 04:03 PM
Ciaffoni JosephPresident and CEOMar 01, 2021 Option Exercise$8.2248,616399,624343,075Mar 03, 2021, 08:02 PM
Ciaffoni JosephPresident and CEOMar 01, 2021 Sale$22.6764,7681,468,425288,116Mar 03, 2021, 08:02 PM
Fleming Alison BChief Technical OfficerJan 19, 2018 Option Exercise$1.953,3246,484157,975Mar 03, 2021, 08:01 PM
Fleming Alison BChief Technical OfficerJan 12, 2018 Option Exercise$0.587,5004,334161,917Mar 03, 2021, 08:01 PM
Fleming Alison BChief Technical OfficerJan 12, 2018 Sale$21.007,500157,500156,164Mar 03, 2021, 08:01 PM
Fleming Alison BChief Technical OfficerMar 01, 2021 Sale$23.366,011140,417148,753Mar 03, 2021, 08:01 PM
Fleming Alison BChief Technical OfficerMay 10, 2018 Sale$27.001,40037,800154,764Mar 03, 2021, 08:01 PM
Fleming Alison BChief Technical OfficerJan 19, 2018 Sale$23.003,32476,452156,164Mar 03, 2021, 08:01 PM
Dreyer ScottEVP & Chief Commercial OfficerFeb 10, 2021 Option Exercise$25.955,184134,52594,439Feb 12, 2021, 04:16 PM
Dreyer ScottEVP & Chief Commercial OfficerFeb 11, 2021 Sale$25.217,898199,13289,056Feb 12, 2021, 04:16 PM
Kuhlmann Shirley R.EVP and General CounselFeb 10, 2021 Option Exercise$25.955,858152,015101,419Feb 12, 2021, 04:16 PM
Fleming Alison BChief Technical OfficerFeb 10, 2021 Option Exercise$25.957,144185,387161,209Feb 12, 2021, 04:15 PM
Ciaffoni JosephPresident and CEOFeb 10, 2021 Option Exercise$25.9523,786617,247309,747Feb 12, 2021, 04:15 PM
Brannelly PaulExecutive Vice President & CFOFeb 10, 2021 Option Exercise$25.958,491220,341221,355Feb 12, 2021, 04:14 PM
Malamut RichardEVP and Chief Medical OfficerFeb 10, 2021 Option Exercise$25.952,30059,68598,219Feb 12, 2021, 04:13 PM
Kuhlmann Shirley R.EVP and General CounselJan 20, 2021 Sale$24.456,081148,680103,582Jan 22, 2021, 04:05 PM
Kuhlmann Shirley R.EVP and General CounselJan 20, 2021 Sale$24.456,081148,680103,582Jan 21, 2021, 04:29 PM
Dreyer ScottEVP & Chief Commercial OfficerJan 15, 2021 Sale$22.891,32230,26144,395Jan 20, 2021, 04:15 PM
Dreyer ScottEVP & Chief Commercial OfficerJan 11, 2021 Option Exercise$21.1870114,84745,717Jan 13, 2021, 04:08 PM
Fleming Alison BChief Technology OfficerJan 07, 2021 Option Exercise$5.7316,04291,921127,461Jan 11, 2021, 05:06 PM
Fleming Alison BChief Technology OfficerJan 19, 2018 Option Exercise$5.733,33619,115114,755Jan 11, 2021, 05:06 PM
Fleming Alison BChief Technology OfficerJan 07, 2021 Sale$22.0016,042352,924111,419Jan 11, 2021, 05:06 PM
Fleming Alison BChief Technology OfficerJan 19, 2018 Sale$23.003,33676,728111,419Jan 11, 2021, 05:06 PM
Ciaffoni JosephPresident and CEOJan 04, 2021 Option Exercise$20.031,09021,833184,256Jan 06, 2021, 04:09 PM
Fleming Alison BChief Technology OfficerDec 03, 2020 Sale$19.245,967114,805111,419Dec 07, 2020, 04:03 PM
Ciaffoni JosephPresident and CEONov 30, 2020 Option Exercise$18.494,67286,385185,346Dec 02, 2020, 05:00 PM
Fleming Alison BChief Technology OfficerNov 18, 2020 Option Exercise$5.7316,00091,680117,386Nov 20, 2020, 04:28 PM
Kuhlmann Shirley R.EVP and General CounselOct 15, 2020 Sale$20.827,060146,98957,531Oct 16, 2020, 04:07 PM
Kuhlmann Shirley R.EVP and General CounselSep 16, 2020 Option Exercise$19.3373414,18864,591Sep 18, 2020, 04:17 PM
Brannelly PaulExecutive Vice President & CFOAug 10, 2020 Option Exercise$18.891,51528,618173,758Aug 12, 2020, 04:06 PM
Ciaffoni JosephPresident and CEOAug 10, 2020 Option Exercise$18.891,38626,182190,018Aug 12, 2020, 04:05 PM
Heffernan Michael ThomasDirectorAug 11, 2020 Sale$19.1313,071250,04854,122Aug 12, 2020, 04:05 PM
Fleming Alison BChief Technology OfficerAug 10, 2020 Option Exercise$18.891,51528,618101,386Aug 12, 2020, 04:04 PM
Dreyer ScottEVP & Chief Commercial OfficerJul 10, 2020 Option Exercise$16.735949,93847,847Jul 14, 2020, 04:06 PM
Dreyer ScottEVP & Chief Commercial OfficerJul 13, 2020 Sale$17.011,42924,30746,418Jul 14, 2020, 04:06 PM
Ciaffoni JosephPresident and CEOJul 01, 2020 Option Exercise$17.371,39424,214191,404Jul 02, 2020, 04:40 PM
Ciaffoni JosephPresident and CEOJun 01, 2020 Option Exercise$21.244,67299,233204,515Jun 02, 2020, 06:58 PM
Ciaffoni JosephPresident and CEOJun 01, 2020 Option Exercise$8.2264,820532,820269,335Jun 02, 2020, 06:58 PM
Ciaffoni JosephPresident and CEOJun 01, 2020 Sale$21.5370,6761,521,709198,759Jun 02, 2020, 06:58 PM
Ciaffoni JosephPresident and CEOJun 02, 2020 Sale$20.485,861120,058192,898Jun 02, 2020, 06:58 PM
Heffernan Michael ThomasDirectorMay 20, 2020 Option Exercise$22.0518,650411,23263,146May 22, 2020, 04:25 PM
Dreyer ScottEVP & Chief Commercial OfficerMay 18, 2020 Option Exercise$15.908,000127,20056,441May 20, 2020, 04:18 PM
Dreyer ScottEVP & Chief Commercial OfficerMay 18, 2020 Sale$24.008,000192,00048,441May 20, 2020, 04:18 PM
Heffernan Michael ThomasDirectorMay 13, 2020 Sale$21.6319,254416,42199,670May 15, 2020, 04:17 PM
Fleming Alison BChief Technology OfficerMay 13, 2020 Sale$21.677,989173,147105,629May 15, 2020, 04:16 PM
Dreyer ScottEVP & Chief Commercial OfficerMay 13, 2020 Sale$22.614,434100,25348,441May 15, 2020, 04:15 PM
Malamut RichardEVP and Chief Medical OfficerApr 01, 2020 Option Exercise$15.492,92045,23159,830Apr 03, 2020, 04:16 PM
Kuhlmann Shirley R.EVP and General CounselMar 16, 2020 Option Exercise$15.4173411,31165,325Mar 18, 2020, 04:16 PM
Brannelly PaulExecutive Vice President & CFOFeb 10, 2020 Option Exercise$21.624,02587,021175,273Feb 12, 2020, 04:32 PM
Ciaffoni JosephPresident and CEOFeb 10, 2020 Option Exercise$21.627,499162,128209,187Feb 12, 2020, 04:30 PM
Fleming Alison BChief Technology OfficerFeb 10, 2020 Option Exercise$21.623,56877,140110,890Feb 12, 2020, 04:28 PM
Dreyer ScottEVP & Chief Commercial OfficerFeb 10, 2020 Option Exercise$21.621,96642,50552,875Feb 12, 2020, 04:27 PM
Kuhlmann Shirley R.EVP and General CounselFeb 10, 2020 Option Exercise$21.622,08545,07866,059Feb 12, 2020, 04:25 PM
Heffernan Michael ThomasDirectorFeb 10, 2020 Option Exercise$21.624,962107,278101,050Feb 12, 2020, 04:22 PM
Heffernan Michael ThomasDirectorJan 21, 2020 Option Exercise$21.5678716,968106,012Jan 22, 2020, 04:29 PM
Heffernan Michael ThomasDirectorJan 21, 2020 Option Exercise$5.73275,4631,578,403402,086Jan 22, 2020, 04:29 PM
Heffernan Michael ThomasDirectorJan 21, 2020 Sale$21.93295,2876,476,863139,499Jan 22, 2020, 04:29 PM
Fleming Alison BChief Technology OfficerJan 21, 2020 Option Exercise$21.562144,61473,342Jan 22, 2020, 04:27 PM
Brannelly PaulExecutive Vice President & CFOJan 21, 2020 Option Exercise$21.562144,614151,173Jan 22, 2020, 04:26 PM
Dreyer ScottEVP & Chief Commercial OfficerJan 14, 2020 Sale$23.871,32131,53235,716Jan 16, 2020, 04:12 PM
Dreyer ScottEVP & Chief Commercial OfficerJan 10, 2020 Option Exercise$23.3070216,35737,037Jan 14, 2020, 04:27 PM
Ciaffoni JosephPresident and CEOJan 02, 2020 Option Exercise$20.581,09122,453171,686Jan 03, 2020, 04:07 PM
Ciaffoni JosephPresident and CEONov 29, 2019 Option Exercise$21.734,678101,653172,777Dec 02, 2019, 04:16 PM
Hirsch DavidDirectorNov 08, 2019 Sale$19.3325,000483,25017,117Nov 13, 2019, 04:33 PM
Fleming Alison BChief Technology OfficerNov 08, 2019 Option Exercise$5.7325,000143,25098,556Nov 13, 2019, 04:32 PM
Fleming Alison BChief Technology OfficerNov 08, 2019 Sale$19.4425,000486,00073,556Nov 13, 2019, 04:32 PM
Ciaffoni JosephPresident and CEONov 07, 2019 Option Exercise$8.2264,821532,829242,276Nov 08, 2019, 04:11 PM
Ciaffoni JosephPresident and CEONov 07, 2019 Sale$18.7764,8211,216,774208,681Nov 08, 2019, 04:11 PM
Kuhlmann Shirley R.EVP and General CounselSep 16, 2019 Option Exercise$12.447369,15643,394Sep 18, 2019, 04:06 PM
Hirsch DavidDirectorAug 29, 2019 Option Exercise$9.3319,853185,22864,223Sep 03, 2019, 06:16 PM
Hirsch DavidDirectorAug 29, 2019 Sale$11.6522,106257,53542,117Sep 03, 2019, 06:16 PM
Fleming Alison BChief Technology OfficerAug 09, 2019 Option Exercise$11.241,51717,05173,556Aug 13, 2019, 04:47 PM
Ciaffoni JosephPresident and CEOAug 09, 2019 Option Exercise$11.2491910,330177,455Aug 13, 2019, 04:46 PM
Heffernan Michael ThomasDirectorAug 09, 2019 Option Exercise$11.244,77953,716126,623Aug 13, 2019, 04:45 PM
Brannelly PaulExecutive Vice President & CFOJul 26, 2019 Option Exercise$9.047977,205152,904Aug 13, 2019, 04:42 PM
Brannelly PaulExecutive Vice President & CFOAug 09, 2019 Option Exercise$11.241,51717,051151,387Aug 13, 2019, 04:42 PM
Fleming Alison BChief Technology OfficerJul 19, 2019 Option Exercise$10.351811,87375,073Jul 23, 2019, 04:04 PM
Heffernan Michael ThomasDirectorJul 19, 2019 Option Exercise$10.356676,903131,402Jul 23, 2019, 04:03 PM
Brannelly PaulExecutive Vice President & CFOJul 19, 2019 Option Exercise$10.351811,873152,107Jul 23, 2019, 04:02 PM
Heffernan Michael ThomasDirectorJul 15, 2019 Sale$11.2625,000281,500132,069Jul 17, 2019, 04:22 PM
Dreyer ScottEVP & Chief Commercial OfficerJul 10, 2019 Option Exercise$12.441,19014,80440,596Jul 12, 2019, 04:08 PM
Dreyer ScottEVP & Chief Commercial OfficerJul 11, 2019 Sale$12.312,85735,17037,739Jul 12, 2019, 04:08 PM
Ciaffoni JosephPresident and CEOJul 01, 2019 Option Exercise$13.211,84824,412178,374Jul 02, 2019, 06:15 PM
Heffernan Michael ThomasDirectorJun 17, 2019 Sale$11.3725,000284,246159,090Jun 19, 2019, 06:05 PM
Ciaffoni JosephPresident and CEOMay 31, 2019 Option Exercise$11.513,09735,646187,658Jun 04, 2019, 04:17 PM
Ciaffoni JosephPresident and CEOJun 03, 2019 Sale$11.597,43686,183180,222Jun 04, 2019, 04:17 PM
Ciaffoni JosephPresident and CEOMay 31, 2019 Sale$11.525,85167,404190,755Jun 04, 2019, 04:17 PM
Heffernan Michael ThomasDirectorMay 15, 2019 Sale$12.8425,000321,042188,586May 17, 2019, 04:04 PM
Heffernan Michael ThomasDirectorApr 15, 2019 Sale$15.0925,000377,366207,170Apr 17, 2019, 04:24 PM
Kuhlmann Shirley R.EVP and General CounselMar 15, 2019 Option Exercise$16.981,47024,96144,130Mar 19, 2019, 05:41 PM
Heffernan Michael ThomasDirectorMar 15, 2019 Sale$17.1725,000429,250227,362Mar 19, 2019, 05:36 PM
Heffernan Michael ThomasDirectorFeb 15, 2019 Sale$14.8125,000370,224259,430Feb 20, 2019, 12:00 AM
Heffernan Michael ThomasDirectorFeb 08, 2019 Option Exercise$14.397,851112,976277,362Feb 11, 2019, 05:06 PM
Fleming Alison BChief Technology OfficerFeb 08, 2019 Option Exercise$14.392,71439,05475,254Feb 11, 2019, 05:03 PM
Ciaffoni JosephPresident and CEOFeb 08, 2019 Option Exercise$14.392,05229,528196,606Feb 11, 2019, 05:01 PM
Brannelly PaulExecutive Vice President & CFOFeb 08, 2019 Option Exercise$14.392,69338,752152,288Feb 11, 2019, 04:59 PM
Fleming Alison BChief Technology OfficerJan 18, 2019 Option Exercise$15.762143,37352,368Jan 23, 2019, 04:17 PM
Heffernan Michael ThomasDirectorJan 18, 2019 Option Exercise$15.7678712,403285,213Jan 23, 2019, 04:14 PM
Brannelly PaulExecutive Vice President & CFOJan 18, 2019 Option Exercise$15.762143,373122,981Jan 23, 2019, 04:13 PM
Heffernan Michael ThomasDirectorJan 15, 2019 Sale$15.5625,000389,000286,000Jan 17, 2019, 04:16 PM
Heffernan Michael ThomasDirectorDec 17, 2018 Sale$18.1825,000454,491314,313Dec 18, 2018, 05:09 PM
Ciaffoni JosephPresident and CEONov 30, 2018 Option Exercise$19.194,68389,867108,658Dec 03, 2018, 05:05 PM
Heffernan Michael ThomasDirectorNov 15, 2018 Sale$16.6025,000415,122339,600Nov 16, 2018, 04:19 PM
Heffernan Michael ThomasDirectorOct 15, 2018 Sale$16.5325,000413,250361,000Oct 17, 2018, 04:27 PM
Brannelly PaulExecutive Vice President & CFOAug 23, 2018 Option Exercise$18.0359910,800123,195Aug 27, 2018, 04:07 PM
Heffernan Michael ThomasDirectorAug 23, 2018 Option Exercise$18.032,02536,511386,000Aug 27, 2018, 04:06 PM
Fleming Alison BChief Technology OfficerAug 23, 2018 Option Exercise$18.0359910,80052,582Aug 27, 2018, 04:04 PM
Brannelly PaulExecutive Vice President & CFOJul 27, 2018 Option Exercise$15.845398,538123,975Aug 06, 2018, 05:43 PM
Brannelly PaulExecutive Vice President & CFOAug 03, 2018 Option Exercise$20.151813,647123,794Aug 06, 2018, 05:43 PM
Heffernan Michael ThomasDirectorAug 03, 2018 Option Exercise$20.1566813,460388,025Aug 06, 2018, 05:41 PM
Fleming Alison BChief Technology OfficerAug 03, 2018 Option Exercise$20.151813,64753,181Aug 06, 2018, 05:39 PM
Brannelly PaulExecutive Vice President & CFOJun 21, 2018 Sale$27.9210,000279,165128,336Jun 22, 2018, 06:25 PM
Fleming Alison BChief Technology OfficerJun 12, 2018 Sale$27.004,096110,59253,362Jun 13, 2018, 04:58 PM
Heffernan Michael ThomasChairman, President and CEOJun 12, 2018 Sale$25.2653,0571,340,220388,693Jun 13, 2018, 04:56 PM
Heffernan Michael ThomasChairman, President and CEOJun 11, 2018 Sale$25.2896,9432,450,719441,750Jun 13, 2018, 04:56 PM
Ciaffoni JosephChief Operating OfficerMay 31, 2018 Option Exercise$22.626,205140,357103,063Jun 04, 2018, 06:00 PM
Ciaffoni JosephChief Operating OfficerMay 31, 2018 Option Exercise$8.2264,821532,829174,089Jun 04, 2018, 06:00 PM
Ciaffoni JosephChief Operating OfficerJun 01, 2018 Sale$22.4814,862334,09888,201Jun 04, 2018, 06:00 PM
Ciaffoni JosephChief Operating OfficerMay 31, 2018 Sale$22.6164,8211,465,615114,885Jun 04, 2018, 06:00 PM
Heffernan Michael ThomasChairman, President and CEOMay 10, 2018 Sale$26.217,100186,100540,193May 14, 2018, 04:32 PM
Heffernan Michael ThomasChairman, President and CEOApr 19, 2018 Sale$26.0044,4001,154,401545,893Apr 23, 2018, 05:05 PM
Fleming Alison BChief Technology OfficerApr 02, 2018 Option Exercise$0.288,1422,28057,458Apr 04, 2018, 04:50 PM
Heffernan Michael ThomasChairman, President and CEOFeb 26, 2018 Option Exercise$21.774,05088,169590,193Mar 01, 2018, 04:04 PM
Brannelly PaulExecutive Vice President & CFOFeb 26, 2018 Option Exercise$21.771,19726,059133,436Mar 01, 2018, 04:03 PM
Fleming Alison BChief Technology OfficerFeb 26, 2018 Option Exercise$21.771,19325,97249,316Mar 01, 2018, 04:03 PM
Brannelly PaulExecutive Vice President & CFOFeb 05, 2018 Option Exercise$23.382145,003134,633Feb 06, 2018, 04:18 PM
Fleming Alison BChief Technology OfficerFeb 05, 2018 Option Exercise$23.382145,00350,509Feb 06, 2018, 04:16 PM
Heffernan Michael ThomasChairman, President and CEOFeb 05, 2018 Option Exercise$23.3878818,423594,243Feb 06, 2018, 04:14 PM
Heffernan Michael ThomasChairman, President and CEOJan 26, 2018 Option Exercise$10.171,04410,617595,031Jan 29, 2018, 07:41 PM
Brannelly PaulExecutive Vice President & CFOJan 26, 2018 Option Exercise$10.171,04410,617134,847Jan 29, 2018, 07:38 PM
Heffernan Michael ThomasChairman, President and CEOJan 23, 2018 Sale$25.0116,408410,364518,987Jan 23, 2018, 05:41 PM
Heffernan Michael ThomasChairman, President and CEOJan 22, 2018 Sale$25.003,59289,800535,395Jan 23, 2018, 05:41 PM
Heffernan Michael ThomasChairman, President and CEOJan 19, 2018 Sale$22.5020,000450,000538,987Jan 19, 2018, 05:41 PM
Fleming Alison BChief Technology OfficerJan 10, 2018 Option Exercise$0.486,9283,32532,651Jan 12, 2018, 04:15 PM
Fleming Alison BChief Technology OfficerJan 10, 2018 Sale$19.076,928132,11725,723Jan 12, 2018, 04:15 PM
Hirsch DavidDirectorDec 08, 2017 Sale$17.3419,650340,73145,620Dec 12, 2017, 04:23 PM
Hirsch DavidDirectorDec 08, 2017 Sale$17.34980,35016,999,2692,276,222Dec 12, 2017, 04:23 PM
Longitude Capital Partners, LLC10% OwnerDec 08, 2017 Sale$17.3419,650340,73145,620Dec 12, 2017, 04:20 PM
Longitude Capital Partners, LLC10% OwnerDec 08, 2017 Sale$17.34980,35016,999,2692,276,222Dec 12, 2017, 04:20 PM
Fleming Alison BChief Technology OfficerNov 17, 2017 Option Exercise$0.283,18989328,513Nov 21, 2017, 05:41 PM
Fleming Alison BChief Technology OfficerNov 21, 2017 Option Exercise$0.2857216026,295Nov 21, 2017, 05:41 PM
Fleming Alison BChief Technology OfficerNov 17, 2017 Sale$17.004,02968,49326,563Nov 21, 2017, 05:41 PM
Fleming Alison BChief Technology OfficerNov 21, 2017 Sale$19.0057210,86825,723Nov 21, 2017, 05:41 PM
Heffernan Michael ThomasChairman, President and CEONov 15, 2017 Sale$15.5350,000776,500558,987Nov 17, 2017, 09:04 PM
Fleming Alison BChief Technology OfficerOct 25, 2017 Option Exercise$3.381,8116,12126,563Oct 27, 2017, 04:58 PM
Heffernan Michael ThomasChairman, President and CEOJul 28, 2017 Option Exercise$10.606406,784609,723Aug 04, 2017, 04:17 PM
Heffernan Michael ThomasChairman, President and CEOAug 04, 2017 Option Exercise$12.397369,119608,987Aug 04, 2017, 04:17 PM
Brannelly PaulExecutive Vice President & CFOJul 28, 2017 Option Exercise$10.607768,226111,003Aug 04, 2017, 04:15 PM
Brannelly PaulExecutive Vice President & CFOAug 04, 2017 Option Exercise$12.392002,478110,803Aug 04, 2017, 04:15 PM
Fleming Alison BChief Technology OfficerJul 28, 2017 Option Exercise$10.606396,77324,952Aug 04, 2017, 04:14 PM
Fleming Alison BChief Technology OfficerAug 04, 2017 Option Exercise$12.392002,47824,752Aug 04, 2017, 04:14 PM
Brannelly PaulExecutive Vice President & CFOMay 12, 2017 Buy$9.1810,00091,800110,227May 15, 2017, 05:26 PM
Heffernan Michael ThomasChairman, President and CEOMar 17, 2017 Option Exercise$14.951,47222,006609,083Mar 21, 2017, 04:45 PM
Brannelly PaulExecutive Vice President & CFOMar 17, 2017 Option Exercise$14.953885,801100,227Mar 21, 2017, 04:44 PM
Duke Barry SSee remarksMar 17, 2017 Option Exercise$14.953885,80120,087Mar 21, 2017, 04:43 PM
Fleming Alison BChief Technology OfficerMar 17, 2017 Option Exercise$14.953885,80124,313Mar 21, 2017, 04:42 PM
Fleming Alison BChief Technology OfficerJan 27, 2017 Option Exercise$10.081,24012,4998,451Feb 14, 2017, 05:56 PM
Duke Barry SSee remarksJan 27, 2017 Option Exercise$10.088348,4076,725Feb 14, 2017, 05:54 PM
Brannelly PaulExecutive Vice President & CFOJan 27, 2017 Option Exercise$10.081,00610,14084,365Feb 14, 2017, 05:53 PM
Heffernan Michael ThomasChairman, President and CEOJan 27, 2017 Option Exercise$10.081,23912,489552,542Feb 02, 2017, 04:26 PM
Heffernan Michael ThomasChairman, President and CEOJan 31, 2017 Option Exercise$0.483,0131,446555,555Feb 02, 2017, 04:26 PM
Fallon John A.DirectorAug 12, 2016 Buy$10.592,37525,1512,375Aug 15, 2016, 08:54 PM
Heffernan Michael ThomasChairman, President and CEOJul 29, 2016 Option Exercise$10.311,21212,496551,303Aug 03, 2016, 04:22 PM
Brannelly PaulExecutive Vice President & CFOJul 29, 2016 Option Exercise$10.3198310,13583,359Aug 03, 2016, 04:20 PM
Duke Barry SSee remarksJul 29, 2016 Option Exercise$10.3197810,0835,891Aug 03, 2016, 04:18 PM
Brannelly PaulExecutive Vice President & CFOMay 20, 2016 Option Exercise$16.891,10018,57982,376May 23, 2016, 12:40 PM
Brannelly PaulExecutive Vice President & CFOMay 18, 2016 Option Exercise$16.0090014,40081,276May 19, 2016, 04:50 PM
Brannelly PaulExecutive Vice President & CFOMay 17, 2016 Option Exercise$15.461,00015,46080,376May 18, 2016, 01:14 PM
Brannelly PaulExecutive Vice President & CFOMay 16, 2016 Option Exercise$15.7380012,58479,376May 16, 2016, 04:40 PM
Brannelly PaulExecutive Vice President & CFOMay 13, 2016 Option Exercise$15.021,20018,02478,576May 13, 2016, 04:26 PM
Heffernan Michael ThomasChairman, President and CEOApr 05, 2016 Option Exercise$2.4913,60433,905387,048Apr 07, 2016, 05:03 PM
Longitude Capital Partners, LLC10% OwnerMay 12, 2015 Buy$12.003,93047,16065,270May 14, 2015, 04:25 PM
Longitude Capital Partners, LLC10% OwnerMay 12, 2015 Buy$12.00196,0702,352,8403,256,572May 14, 2015, 04:25 PM
Heron Patrick JDirectorMay 12, 2015 Buy$12.00150,0001,800,0001,887,332May 14, 2015, 04:06 PM
Frazier Healthcare VI, L.P.10% OwnerMay 12, 2015 Buy$12.00150,0001,800,0001,887,332May 14, 2015, 04:06 PM
TPG Group Holdings (SBS) Advisors, Inc.Former 10% OwnerMay 12, 2015 Buy$12.00100,0001,200,0001,325,253May 14, 2015, 02:55 PM
Skyline Venture Partners V LP10% OwnerMay 12, 2015 Buy$12.00150,0001,800,0002,949,916May 13, 2015, 09:41 PM
Hirsch DavidDirectorMay 12, 2015 Buy$12.003,93047,16065,270May 13, 2015, 04:37 PM
Hirsch DavidDirectorMay 12, 2015 Buy$12.00196,0702,352,8403,256,572May 13, 2015, 04:37 PM
Freund John GordonDirectorMay 12, 2015 Buy$12.00150,0001,800,0002,949,916May 13, 2015, 04:31 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Smith Thomas BEVP and Chief Medical Officer02/29/202436,580
Dreyer ScottEVP & Chief Commercial Officer02/26/2024364,270
Tupper ColleenEVP & Chief Financial Officer02/12/2024887,018
Dreyer ScottEVP & Chief Commercial Officer02/12/20241,000,553
Smith Thomas BEVP and Chief Medical Officer02/12/2024107,806
Kuhlmann Shirley R.EVP and General Counsel02/12/20241,070,177
Ciaffoni JosephPresident and CEO02/12/20244,342,818
Dreyer ScottEVP & Chief Commercial Officer01/16/2024760,519
Ciaffoni JosephPresident and CEO12/21/202392,978
Ciaffoni JosephPresident and CEO12/21/2023132,377
Ciaffoni JosephPresident and CEO12/20/2023564,528
Ciaffoni JosephPresident and CEO12/19/2023309,771
Ciaffoni JosephPresident and CEO12/18/2023593,209
Ciaffoni JosephPresident and CEO12/20/2023804,210
Ciaffoni JosephPresident and CEO12/19/2023435,942
Ciaffoni JosephPresident and CEO12/18/2023834,935
Kuhlmann Shirley R.EVP and General Counsel11/27/2023407,040
Kuhlmann Shirley R.EVP and General Counsel11/27/2023660,014
Kuhlmann Shirley R.EVP and General Counsel06/26/2023390,633
Ciaffoni JosephPresident and CEO06/02/2023675,424
Ciaffoni JosephPresident and CEO06/01/2023690,758
Ciaffoni JosephPresident and CEO05/31/2023683,797
Ciaffoni JosephPresident and CEO05/30/2023684,907
Tupper ColleenEVP & Chief Financial Officer03/15/2023752,165
Kuhlmann Shirley R.EVP and General Counsel02/10/2023643,231
Kuhlmann Shirley R.EVP and General Counsel02/13/2023586,280
Tupper ColleenEVP & Chief Financial Officer02/10/2023290,345
Ciaffoni JosephPresident and CEO02/10/20232,778,175
Ciaffoni JosephPresident and CEO02/13/2023178,875
Ciaffoni JosephPresident and CEO02/13/2023302,400
Dreyer ScottEVP & Chief Commercial Officer02/10/2023570,471
Dreyer ScottEVP & Chief Commercial Officer01/09/2023488,554
Heffernan Michael ThomasDirector12/27/2022320,012
Heffernan Michael ThomasDirector12/23/202280,572
Heffernan Michael ThomasDirector12/22/20223,828
Heffernan Michael ThomasDirector12/23/2022114,747
Heffernan Michael ThomasDirector12/22/20225,451
Heffernan Michael ThomasDirector12/27/2022470,253
Ciaffoni JosephPresident and CEO12/27/202252,341
Ciaffoni JosephPresident and CEO12/23/20223,381
Ciaffoni JosephPresident and CEO12/22/20222,530
Heffernan Michael ThomasDirector12/19/202258,237
Heffernan Michael ThomasDirector12/21/2022752,590
Heffernan Michael ThomasDirector12/20/2022545,192
Heffernan Michael ThomasDirector12/21/20221,076,926
Heffernan Michael ThomasDirector12/20/2022779,135
Heffernan Michael ThomasDirector12/19/202283,082
Ciaffoni JosephPresident and CEO12/19/202226,093
Ciaffoni JosephPresident and CEO12/21/2022169,466
Ciaffoni JosephPresident and CEO12/20/2022216,281
Heffernan Michael ThomasDirector12/13/20222,441,404
Heffernan Michael ThomasDirector12/12/2022421,334
Heffernan Michael ThomasDirector12/13/20223,582,984
Heffernan Michael ThomasDirector12/12/2022614,519
Ciaffoni JosephPresident and CEO12/01/20221,218,783
Ciaffoni JosephPresident and CEO12/02/20221,255,008
Ciaffoni JosephPresident and CEO12/01/20221,722,393
Ciaffoni JosephPresident and CEO11/28/2022684
Ciaffoni JosephPresident and CEO11/28/2022946
Ciaffoni JosephPresident and CEO11/22/20221,033
Ciaffoni JosephPresident and CEO11/22/20221,430
Ciaffoni JosephPresident and CEO11/18/202231,625
Ciaffoni JosephPresident and CEO11/18/202243,798
Tupper ColleenEVP & Chief Financial Officer10/04/202275,473
Kuhlmann Shirley R.EVP and General Counsel09/15/2022697,303
Kuhlmann Shirley R.EVP and General Counsel08/11/20226,003
Dreyer ScottEVP & Chief Commercial Officer07/11/202210,383
Ciaffoni JosephPresident and CEO07/01/202225,315
Kuhlmann Shirley R.EVP and General Counsel03/16/202213,939
Ciaffoni JosephPresident and CEO03/01/20221,405,224
Tupper ColleenEVP & Chief Financial Officer02/10/202271,543
Dreyer ScottEVP & Chief Commercial Officer02/18/2022228,180
Malamut RichardEVP and Chief Medical Officer02/10/2022111,069
Tupper ColleenEVP & Chief Financial Officer02/10/202271,543
Ciaffoni JosephPresident and CEO02/10/2022934,337
Kuhlmann Shirley R.EVP and General Counsel02/10/2022197,086
Dreyer ScottEVP & Chief Commercial Officer02/10/2022187,918
Dreyer ScottEVP & Chief Commercial Officer01/10/202213,354
Ciaffoni JosephPresident and CEO01/03/202220,361
Dreyer ScottEVP & Chief Commercial Officer12/15/2021104,353
Kuhlmann Shirley R.EVP and General Counsel09/16/202114,438
Fleming Alison BEVP & Chief Technical Officer08/10/202126,376
Ciaffoni JosephPresident and CEO08/10/202126,376
Dreyer ScottEVP & Chief Commercial Officer07/12/202113,786
Ciaffoni JosephPresident and CEO07/01/202133,442
Kuhlmann Shirley R.EVP and General Counsel05/10/2021159,390
Malamut RichardEVP and Chief Medical Officer04/01/202172,922
Fleming Alison BEVP & Chief Technical Officer04/01/2021225,781
Kuhlmann Shirley R.EVP and General Counsel03/16/202118,122
Heffernan Michael ThomasDirector03/15/20211,266,774
Ciaffoni JosephPresident and CEO03/01/2021399,624
Ciaffoni JosephPresident and CEO03/01/20211,468,425
Fleming Alison BChief Technical Officer01/19/20186,484
Fleming Alison BChief Technical Officer01/12/20184,334
Fleming Alison BChief Technical Officer01/12/2018157,500
Fleming Alison BChief Technical Officer03/01/2021140,417
Fleming Alison BChief Technical Officer05/10/201837,800
Fleming Alison BChief Technical Officer01/19/201876,452
Dreyer ScottEVP & Chief Commercial Officer02/10/2021134,525
Dreyer ScottEVP & Chief Commercial Officer02/11/2021199,132
Kuhlmann Shirley R.EVP and General Counsel02/10/2021152,015
Fleming Alison BChief Technical Officer02/10/2021185,387
Ciaffoni JosephPresident and CEO02/10/2021617,247
Brannelly PaulExecutive Vice President & CFO02/10/2021220,341
Malamut RichardEVP and Chief Medical Officer02/10/202159,685
Kuhlmann Shirley R.EVP and General Counsel01/20/2021148,680
Kuhlmann Shirley R.EVP and General Counsel01/20/2021148,680
Dreyer ScottEVP & Chief Commercial Officer01/15/202130,261
Dreyer ScottEVP & Chief Commercial Officer01/11/202114,847
Fleming Alison BChief Technology Officer01/07/202191,921
Fleming Alison BChief Technology Officer01/19/201819,115
Fleming Alison BChief Technology Officer01/07/2021352,924
Fleming Alison BChief Technology Officer01/19/201876,728
Ciaffoni JosephPresident and CEO01/04/202121,833
Fleming Alison BChief Technology Officer12/03/2020114,805
Ciaffoni JosephPresident and CEO11/30/202086,385
Fleming Alison BChief Technology Officer11/18/202091,680
Kuhlmann Shirley R.EVP and General Counsel10/15/2020146,989
Kuhlmann Shirley R.EVP and General Counsel09/16/202014,188
Brannelly PaulExecutive Vice President & CFO08/10/202028,618
Ciaffoni JosephPresident and CEO08/10/202026,182
Heffernan Michael ThomasDirector08/11/2020250,048
Fleming Alison BChief Technology Officer08/10/202028,618
Dreyer ScottEVP & Chief Commercial Officer07/10/20209,938
Dreyer ScottEVP & Chief Commercial Officer07/13/202024,307
Ciaffoni JosephPresident and CEO07/01/202024,214
Ciaffoni JosephPresident and CEO06/01/202099,233
Ciaffoni JosephPresident and CEO06/01/2020532,820
Ciaffoni JosephPresident and CEO06/01/20201,521,709
Ciaffoni JosephPresident and CEO06/02/2020120,058
Heffernan Michael ThomasDirector05/20/2020411,232
Dreyer ScottEVP & Chief Commercial Officer05/18/2020127,200
Dreyer ScottEVP & Chief Commercial Officer05/18/2020192,000
Heffernan Michael ThomasDirector05/13/2020416,421
Fleming Alison BChief Technology Officer05/13/2020173,147
Dreyer ScottEVP & Chief Commercial Officer05/13/2020100,253
Malamut RichardEVP and Chief Medical Officer04/01/202045,231
Kuhlmann Shirley R.EVP and General Counsel03/16/202011,311
Brannelly PaulExecutive Vice President & CFO02/10/202087,021
Ciaffoni JosephPresident and CEO02/10/2020162,128
Fleming Alison BChief Technology Officer02/10/202077,140
Dreyer ScottEVP & Chief Commercial Officer02/10/202042,505
Kuhlmann Shirley R.EVP and General Counsel02/10/202045,078
Heffernan Michael ThomasDirector02/10/2020107,278
Heffernan Michael ThomasDirector01/21/202016,968
Heffernan Michael ThomasDirector01/21/20201,578,403
Heffernan Michael ThomasDirector01/21/20206,476,863
Fleming Alison BChief Technology Officer01/21/20204,614
Brannelly PaulExecutive Vice President & CFO01/21/20204,614
Dreyer ScottEVP & Chief Commercial Officer01/14/202031,532
Dreyer ScottEVP & Chief Commercial Officer01/10/202016,357
Ciaffoni JosephPresident and CEO01/02/202022,453
Ciaffoni JosephPresident and CEO11/29/2019101,653
Hirsch DavidDirector11/08/2019483,250
Fleming Alison BChief Technology Officer11/08/2019143,250
Fleming Alison BChief Technology Officer11/08/2019486,000
Ciaffoni JosephPresident and CEO11/07/2019532,829
Ciaffoni JosephPresident and CEO11/07/20191,216,774
Kuhlmann Shirley R.EVP and General Counsel09/16/20199,156
Hirsch DavidDirector08/29/2019185,228
Hirsch DavidDirector08/29/2019257,535
Fleming Alison BChief Technology Officer08/09/201917,051
Ciaffoni JosephPresident and CEO08/09/201910,330
Heffernan Michael ThomasDirector08/09/201953,716
Brannelly PaulExecutive Vice President & CFO07/26/20197,205
Brannelly PaulExecutive Vice President & CFO08/09/201917,051
Fleming Alison BChief Technology Officer07/19/20191,873
Heffernan Michael ThomasDirector07/19/20196,903
Brannelly PaulExecutive Vice President & CFO07/19/20191,873
Heffernan Michael ThomasDirector07/15/2019281,500
Dreyer ScottEVP & Chief Commercial Officer07/10/201914,804
Dreyer ScottEVP & Chief Commercial Officer07/11/201935,170
Ciaffoni JosephPresident and CEO07/01/201924,412
Heffernan Michael ThomasDirector06/17/2019284,246
Ciaffoni JosephPresident and CEO05/31/201935,646
Ciaffoni JosephPresident and CEO06/03/201986,183
Ciaffoni JosephPresident and CEO05/31/201967,404
Heffernan Michael ThomasDirector05/15/2019321,042
Heffernan Michael ThomasDirector04/15/2019377,366
Kuhlmann Shirley R.EVP and General Counsel03/15/201924,961
Heffernan Michael ThomasDirector03/15/2019429,250
Heffernan Michael ThomasDirector02/15/2019370,224
Heffernan Michael ThomasDirector02/08/2019112,976
Fleming Alison BChief Technology Officer02/08/201939,054
Ciaffoni JosephPresident and CEO02/08/201929,528
Brannelly PaulExecutive Vice President & CFO02/08/201938,752
Fleming Alison BChief Technology Officer01/18/20193,373
Heffernan Michael ThomasDirector01/18/201912,403
Brannelly PaulExecutive Vice President & CFO01/18/20193,373
Heffernan Michael ThomasDirector01/15/2019389,000
Heffernan Michael ThomasDirector12/17/2018454,491
Ciaffoni JosephPresident and CEO11/30/201889,867
Heffernan Michael ThomasDirector11/15/2018415,122
Heffernan Michael ThomasDirector10/15/2018413,250
Brannelly PaulExecutive Vice President & CFO08/23/201810,800
Heffernan Michael ThomasDirector08/23/201836,511
Fleming Alison BChief Technology Officer08/23/201810,800
Brannelly PaulExecutive Vice President & CFO07/27/20188,538
Brannelly PaulExecutive Vice President & CFO08/03/20183,647
Heffernan Michael ThomasDirector08/03/201813,460
Fleming Alison BChief Technology Officer08/03/20183,647
Brannelly PaulExecutive Vice President & CFO06/21/2018279,165
Fleming Alison BChief Technology Officer06/12/2018110,592
Heffernan Michael ThomasChairman, President and CEO06/12/20181,340,220
Heffernan Michael ThomasChairman, President and CEO06/11/20182,450,719
Ciaffoni JosephChief Operating Officer05/31/2018140,357
Ciaffoni JosephChief Operating Officer05/31/2018532,829
Ciaffoni JosephChief Operating Officer06/01/2018334,098
Ciaffoni JosephChief Operating Officer05/31/20181,465,615
Heffernan Michael ThomasChairman, President and CEO05/10/2018186,100
Heffernan Michael ThomasChairman, President and CEO04/19/20181,154,401
Fleming Alison BChief Technology Officer04/02/20182,280
Heffernan Michael ThomasChairman, President and CEO02/26/201888,169
Brannelly PaulExecutive Vice President & CFO02/26/201826,059
Fleming Alison BChief Technology Officer02/26/201825,972
Brannelly PaulExecutive Vice President & CFO02/05/20185,003
Fleming Alison BChief Technology Officer02/05/20185,003
Heffernan Michael ThomasChairman, President and CEO02/05/201818,423
Heffernan Michael ThomasChairman, President and CEO01/26/201810,617
Brannelly PaulExecutive Vice President & CFO01/26/201810,617
Heffernan Michael ThomasChairman, President and CEO01/23/2018410,364
Heffernan Michael ThomasChairman, President and CEO01/22/201889,800
Heffernan Michael ThomasChairman, President and CEO01/19/2018450,000
Fleming Alison BChief Technology Officer01/10/20183,325
Fleming Alison BChief Technology Officer01/10/2018132,117
Hirsch DavidDirector12/08/2017340,731
Hirsch DavidDirector12/08/201716,999,269
Longitude Capital Partners, LLC10% Owner12/08/2017340,731
Longitude Capital Partners, LLC10% Owner12/08/201716,999,269
Fleming Alison BChief Technology Officer11/17/2017893
Fleming Alison BChief Technology Officer11/21/2017160
Fleming Alison BChief Technology Officer11/17/201768,493
Fleming Alison BChief Technology Officer11/21/201710,868
Heffernan Michael ThomasChairman, President and CEO11/15/2017776,500
Fleming Alison BChief Technology Officer10/25/20176,121
Heffernan Michael ThomasChairman, President and CEO07/28/20176,784
Heffernan Michael ThomasChairman, President and CEO08/04/20179,119
Brannelly PaulExecutive Vice President & CFO07/28/20178,226
Brannelly PaulExecutive Vice President & CFO08/04/20172,478
Fleming Alison BChief Technology Officer07/28/20176,773
Fleming Alison BChief Technology Officer08/04/20172,478
Brannelly PaulExecutive Vice President & CFO05/12/201791,800
Heffernan Michael ThomasChairman, President and CEO03/17/201722,006
Brannelly PaulExecutive Vice President & CFO03/17/20175,801
Duke Barry SSee remarks03/17/20175,801
Fleming Alison BChief Technology Officer03/17/20175,801
Fleming Alison BChief Technology Officer01/27/201712,499
Duke Barry SSee remarks01/27/20178,407
Brannelly PaulExecutive Vice President & CFO01/27/201710,140
Heffernan Michael ThomasChairman, President and CEO01/27/201712,489
Heffernan Michael ThomasChairman, President and CEO01/31/20171,446
Fallon John A.Director08/12/201625,151
Heffernan Michael ThomasChairman, President and CEO07/29/201612,496
Brannelly PaulExecutive Vice President & CFO07/29/201610,135
Duke Barry SSee remarks07/29/201610,083
Brannelly PaulExecutive Vice President & CFO05/20/201618,579
Brannelly PaulExecutive Vice President & CFO05/18/201614,400
Brannelly PaulExecutive Vice President & CFO05/17/201615,460
Brannelly PaulExecutive Vice President & CFO05/16/201612,584
Brannelly PaulExecutive Vice President & CFO05/13/201618,024
Heffernan Michael ThomasChairman, President and CEO04/05/201633,905
Longitude Capital Partners, LLC10% Owner05/12/201547,160
Longitude Capital Partners, LLC10% Owner05/12/20152,352,840
Heron Patrick JDirector05/12/20151,800,000
Frazier Healthcare VI, L.P.10% Owner05/12/20151,800,000
TPG Group Holdings (SBS) Advisors, Inc.Former 10% Owner05/12/20151,200,000
Skyline Venture Partners V LP10% Owner05/12/20151,800,000
Hirsch DavidDirector05/12/201547,160
Hirsch DavidDirector05/12/20152,352,840
Freund John GordonDirector05/12/20151,800,000
Load More Insider Transactions
FUNDS WITH A POSITION IN COLLEGIUM PHARMACEUTICAL INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.5,786,9930.00454%-7.27%Other
RENAISSANCE TECHNOLOGIES LLC1,384,5980.07%18.08%Other
GEODE CAPITAL MANAGEMENT, LLC731,2660.00236%2.87%Other
D. E. SHAW & CO., INC.221,5050.00596%52.6%Other
ROYCE & ASSOCIATES LP143,0830.04%573.97%Value
AQR CAPITAL MANAGEMENT LLC105,1660.00609%0.7%Other
THIRD AVENUE MANAGEMENT LLC83,1200.42%NewValue
EASTERLY INVESTMENT PARTNERS LLC49,6510.16%No changeOther
GOTHAM ASSET MANAGEMENT, LLC44,8620.03%4.42%Other
BALYASNY ASSET MANAGEMENT L.P.14,8180.00086%NewEvent Driven
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)8,6670.00493%NewOther
CHANGE IN SHARES OUTSTANDING FOR COLLEGIUM PHARMACEUTICAL INC
STOCK BUYBACKS FOR COLLEGIUM PHARMACEUTICAL INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
-0.64%
1Q
12/31/2023
06/30/2023
-2.48%
2Q
12/31/2023
03/31/2023
21.76%
3Q
12/31/2023
12/31/2022
24.45%
4Q
12/31/2023
09/30/2022
20.88%
5Q
12/31/2023
06/30/2022
22.90%
6Q
12/31/2023
03/31/2022
24.10%
7Q
12/31/2023
12/31/2021
3.54%
8Q
12/31/2023
09/30/2021
15.24%
9Q
12/31/2023
06/30/2021
1.21%
10Q
12/31/2023
03/31/2021
1.53%
11Q
12/31/2023
12/31/2020
17.91%
12Q
12/31/2023
09/30/2020
19.16%
13Q
12/31/2023
06/30/2020
19.08%
14Q
12/31/2023
03/31/2020
19.16%
15Q
12/31/2023
12/31/2019
23.87%
16Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
-0.64%
1Q
06/30/2023
-2.48%
2Q
03/31/2023
21.76%
3Q
12/31/2022
24.45%
4Q
09/30/2022
20.88%
5Q
06/30/2022
22.90%
6Q
03/31/2022
24.10%
7Q
12/31/2021
3.54%
8Q
09/30/2021
15.24%
9Q
06/30/2021
1.21%
10Q
03/31/2021
1.53%
11Q
12/31/2020
17.91%
12Q
09/30/2020
19.16%
13Q
06/30/2020
19.08%
14Q
03/31/2020
19.16%
15Q
12/31/2019
23.87%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR COLLEGIUM PHARMACEUTICAL INC
LOADING...